About us

Quiet Therapeutics is a cancer drug discovery and development company that is creating a new generation of cancer therapeutics utilizing its proprietary GAGomer technology to specifically target tumor cells. Quiet’s core GAGomer technology was developed at Tel Aviv University by Professors Dan Peer and Rimona Margalit. The company was founded and incubated in Ness Ziona Israel, where the potential to specifically deliver anti-cancer agents, including nucleic acid based therapies, was proven.

Seeking to realize the full potential of the technology and to develop novel proprietary therapies in the field of immuno-oncology, Quiet Therapeutics has expanded its research and development footprint; launching a growing team in the greater Boston-Cambridge biotech area.